Novo Nordisk Stock Quote NOV - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

106.28

Bid

106.16

Ask

106.40

Volume

75,968

106.12 Day's Range 107.70

82.01 52 Week Range 139.88

Market Cap

477.836B

Previous Close

106.74

Open

106.62

Last Trade

1300

106.32

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

61,017

Shares Outstanding

4,496,011,436

Dividend Yield

69.48%

PE Ratio

6.35

Earnings Per Share (EPS)

18.61

Revenue

232.26B

Net Profit

83.68B

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.novonordisk.com

Headquarters

Bagsvaerd, Dnk

Founded

Novo Nordisk is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker NOV. The last closing price for Novo Nordisk was 106.74 €. Over the last year, Novo Nordisk shares have traded in a share price range of 82.01 € to 139.88 €.

Novo Nordisk currently has 4,496,011,436 shares outstanding. The market capitalization of Novo Nordisk is 479.90 € billion. Novo Nordisk has a price to earnings ratio (PE ratio) of 6.35.

Novo Nordisk A/S – Share repurchase programme

Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 30 September 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 23 September 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of...

Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed

Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed Bagsværd, Denmark, 20 September 2024 – Novo Nordisk today announced headline results from a phase 2a clinical trial...

Novo Nordisk A/S: Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function

Novo Nordisk A/S: Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function Wegovy® recommended by the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-5.72	-5.10714285714	112	115.64	105.06	83721	109.26358083	DE
4	-17.8	-14.3455834945	124.08	126.32	105.06	52535	114.98860844	DE
12	-26.54	-19.9819304322	132.82	132.82	105.06	61017	118.92055697	DE
26	-13.7	-11.4185697616	119.98	139.88	105.06	58768	121.39950942	DE
52	19.66	22.6968367583	86.62	139.88	82.01	65807	111.147354	DE
156	14.58	15.8996728462	91.7	139.88	82.01	64981	110.29915639	DE
260	14.58	15.8996728462	91.7	139.88	82.01	64981	110.29915639	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
29ZAgEagle Aerial Systems Inc	0.139 € (68.48%)	713.07k
7S2Scotch Creek Ventures Inc	0.0208 € (38.67%)	40k
RT5New World Solutions Inc	0.0253 € (37.50%)	1.03M
A3YAltech Batteries Ltd	0.035 € (35.66%)	1.39M
Q3Q0Discovery Lithium Inc	0.0705 € (31.78%)	1.88k
2JQGritstone Bio Inc	0.1933 € (-62.76%)	235.52k
CNWCodon AG	0.0065 € (-48.00%)	899
FWR0Yumy Candy Company Inc the	0.032 € (-46.67%)	23.47k
7GUGoviEx Uranium Inc	0.0564 € (-39.68%)	596.5k
OU5AAvalon Advanced Materials Inc	0.02 € (-37.11%)	789
D7GNel ASA	0.398 € (-5.49%)	10.58M
BT81PowerHouse Energy Group Plc	0.0134 € (9.84%)	2.26M
6GQEnergy Plug Technologies Corp	0.0304 € (-11.63%)	2.23M
QC8AFC Energy Plc	0.1276 € (-13.43%)	2.07M
LHADeutsche Lufthansa AG	6.438 € (-1.95%)	1.87M